Risks Of ADT in Recurrent Prostate Cancer

Please click on this link to create a free Prostate Cancer video channel subscription. What are the risks of early ADT in men with biochemically recurrent prostate cancer? Dr. VanderWeele specializes in the treatment of genitourinary (GU) cancer from a medical oncology perspective. His research efforts have focused especially on altering the course of potentially lethal GU cancers using targeted therapies. Interviewed by Darryl Mitteldorf, LCSW from Malecare prostate cancer information at https://malecare.org/ Please click the SUBSCRIBE button for more videos from this years prostate cancer patient conference.

• #nonprofits_activism
• #risks_of_early_adt_in_men_with_biochemically_recurrent_prostate_cancer
• #vanderweehle
• #malecare
• #prostate_cancer